Shaoguang Sun

Title: Innovations of Shaoguang Sun in Pharmaceutical Chemistry

Introduction

Shaoguang Sun is a notable inventor based in Sichuan, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of Ticagrelor, a medication used to reduce the risk of heart attacks and strokes.

Latest Patents

Shaoguang Sun holds a patent for the "Intermediate of Ticagrelor and preparation method therefor." This patent discloses intermediates of Ticagrelor and a preparation method for the drug. Specifically, it introduces a compound of Formula (VI) that is essential for preparing Ticagrelor. The method described simplifies the synthesis process, avoiding the long reaction times and high temperatures required in existing methods. This innovation is suitable for mass production, reducing energy consumption, environmental pollution, and waste discharge.

Career Highlights

Throughout his career, Shaoguang Sun has worked with prominent companies in the pharmaceutical industry. He has been associated with Jiangsu Hengrui Medicine Company Ltd. and Suncadia Pharmaceuticals Co., Ltd. His work in these organizations has contributed to advancements in drug development and production.

Collaborations

Shaoguang Sun has collaborated with notable professionals in his field, including Defu Song and Biao He. These collaborations have further enhanced his research and development efforts in pharmaceutical innovations.

Conclusion

Shaoguang Sun's contributions to the field of pharmaceutical chemistry, particularly through his patent on Ticagrelor, highlight his innovative approach to drug development. His work not only simplifies the synthesis process but also addresses environmental concerns, making a significant impact in the industry.